LACTB and infection: The increase in the DDD of amoxicillin/clavulanic acid and ampicillin/sulbactam may reflect an escalation in infections requiring broad-spectrum beta-lactamase inhibitors, possibly due to the increasing prevalence of beta-lactamase-producing organisms (Bookstaver et al., 2017).